Canada markets closed

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1138-0.0062 (-5.17%)
At close: 03:29PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 686.58k
Enterprise Value 436.30k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.70
Price/Book (mrq)2.93
Enterprise Value/Revenue 1.74
Enterprise Value/EBITDA -1.39

Trading Information

Stock Price History

Beta (5Y Monthly) 1.50
52-Week Change 3533.33%
S&P500 52-Week Change 320.07%
52 Week High 30.2000
52 Week Low 30.0040
50-Day Moving Average 30.0703
200-Day Moving Average 30.0273

Share Statistics

Avg Vol (3 month) 310.05k
Avg Vol (10 day) 32.69k
Shares Outstanding 55.91M
Implied Shares Outstanding 66.03M
Float 85.72M
% Held by Insiders 13.22%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 12, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Nov 30, 2023
Most Recent Quarter (mrq)Nov 30, 2023


Profit Margin -119.85%
Operating Margin (ttm)-125.43%

Management Effectiveness

Return on Assets (ttm)-33.54%
Return on Equity (ttm)-64.49%

Income Statement

Revenue (ttm)250.32k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-300k
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)344.63k
Total Cash Per Share (mrq)0.06
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.64
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-359.93k
Levered Free Cash Flow (ttm)-251.78k